295 related articles for article (PubMed ID: 28771489)
1. Additional value of screening for minor genes and copy number variants in hypertrophic cardiomyopathy.
Mademont-Soler I; Mates J; Yotti R; Espinosa MA; Pérez-Serra A; Fernandez-Avila AI; Coll M; Méndez I; Iglesias A; Del Olmo B; Riuró H; Cuenca S; Allegue C; Campuzano O; Picó F; Ferrer-Costa C; Álvarez P; Castillo S; Garcia-Pavia P; Gonzalez-Lopez E; Padron-Barthe L; Díaz de Bustamante A; Darnaude MT; González-Hevia JI; Brugada J; Fernandez-Aviles F; Brugada R
PLoS One; 2017; 12(8):e0181465. PubMed ID: 28771489
[TBL] [Abstract][Full Text] [Related]
2. Spectrum of Mutations in Hypertrophic Cardiomyopathy Genes Among Tunisian Patients.
Jaafar N; Gómez J; Kammoun I; Zairi I; Amara WB; Kachboura S; Kraiem S; Hammami M; Iglesias S; Alonso B; Coto E
Genet Test Mol Biomarkers; 2016 Nov; 20(11):674-679. PubMed ID: 27574918
[TBL] [Abstract][Full Text] [Related]
3. Diagnostic yield, interpretation, and clinical utility of mutation screening of sarcomere encoding genes in Danish hypertrophic cardiomyopathy patients and relatives.
Andersen PS; Havndrup O; Hougs L; Sørensen KM; Jensen M; Larsen LA; Hedley P; Thomsen AR; Moolman-Smook J; Christiansen M; Bundgaard H
Hum Mutat; 2009 Mar; 30(3):363-70. PubMed ID: 19035361
[TBL] [Abstract][Full Text] [Related]
4. Mutation spectrum in a large cohort of unrelated consecutive patients with hypertrophic cardiomyopathy.
Erdmann J; Daehmlow S; Wischke S; Senyuva M; Werner U; Raible J; Tanis N; Dyachenko S; Hummel M; Hetzer R; Regitz-Zagrosek V
Clin Genet; 2003 Oct; 64(4):339-49. PubMed ID: 12974739
[TBL] [Abstract][Full Text] [Related]
5. Use of high-throughput targeted exome-sequencing to screen for copy number variation in hypertrophic cardiomyopathy.
Lopes LR; Murphy C; Syrris P; Dalageorgou C; McKenna WJ; Elliott PM; Plagnol V
Eur J Med Genet; 2015 Nov; 58(11):611-6. PubMed ID: 26455666
[TBL] [Abstract][Full Text] [Related]
6. The prevalence of Fabry disease among 1009 unrelated patients with hypertrophic cardiomyopathy: a Russian nationwide screening program using NGS technology.
Savostyanov K; Pushkov A; Zhanin I; Mazanova N; Trufanov S; Pakhomov A; Alexeeva A; Sladkov D; Asanov A; Fisenko A
Orphanet J Rare Dis; 2022 May; 17(1):199. PubMed ID: 35578305
[TBL] [Abstract][Full Text] [Related]
7. A Next-Generation Sequencing Approach to Identify Gene Mutations in Early- and Late-Onset Hypertrophic Cardiomyopathy Patients of an Italian Cohort.
Rubattu S; Bozzao C; Pennacchini E; Pagannone E; Musumeci BM; Piane M; Germani A; Savio C; Francia P; Volpe M; Autore C; Chessa L
Int J Mol Sci; 2016 Jul; 17(8):. PubMed ID: 27483260
[TBL] [Abstract][Full Text] [Related]
8. Screening of the
Gómez J; Lorca R; Reguero JR; Morís C; Martín M; Tranche S; Alonso B; Iglesias S; Alvarez V; Díaz-Molina B; Avanzas P; Coto E
Circ Cardiovasc Genet; 2017 Apr; 10(2):. PubMed ID: 28356264
[TBL] [Abstract][Full Text] [Related]
9. Mutation analysis of the main hypertrophic cardiomyopathy genes using multiplex amplification and semiconductor next-generation sequencing.
Gómez J; Reguero JR; Morís C; Martín M; Alvarez V; Alonso B; Iglesias S; Coto E
Circ J; 2014; 78(12):2963-71. PubMed ID: 25342278
[TBL] [Abstract][Full Text] [Related]
10. A DNA resequencing array for pathogenic mutation detection in hypertrophic cardiomyopathy.
Fokstuen S; Lyle R; Munoz A; Gehrig C; Lerch R; Perrot A; Osterziel KJ; Geier C; Beghetti M; Mach F; Sztajzel J; Sigwart U; Antonarakis SE; Blouin JL
Hum Mutat; 2008 Jun; 29(6):879-85. PubMed ID: 18409188
[TBL] [Abstract][Full Text] [Related]
11. Genetic basis and outcome in a nationwide study of Finnish patients with hypertrophic cardiomyopathy.
Jääskeläinen P; Vangipurapu J; Raivo J; Kuulasmaa T; Heliö T; Aalto-Setälä K; Kaartinen M; Ilveskoski E; Vanninen S; Hämäläinen L; Melin J; Kokkonen J; Nieminen MS; ; Laakso M; Kuusisto J
ESC Heart Fail; 2019 Apr; 6(2):436-445. PubMed ID: 30775854
[TBL] [Abstract][Full Text] [Related]
12. The Definition of Sarcomeric and Non-Sarcomeric Gene Mutations in Hypertrophic Cardiomyopathy Patients: A Multicenter Diagnostic Study Across Türkiye.
Oktay V; Tüfekçioğlu O; Yılmaz DÇ; Onrat E; Karabulut D; Çelik M; Balcıoğlu AS; Sucu MM; Özdemir G; Kaya H; Kış M; Güven B; Bağdatoğlu O; Turhan Çağlar FN; Yüksel UÇ; Düzen İV; Barutçu A; Şimşir ÖS; Başarıcı İ; Parspur A; Dalgıç O; Arıcan Özlük FÖ; Evlice M; Sağ S; Deniz MF; Öcal A; Gazi E; Şen T; Özdabakoğlu O; Bayar Çakıcı N; Bakır EO; Ülgen Kunak A; Çaylı G; Gül Taşdelen A; Akşit E; Uslu Çil Ş; Onay H
Anatol J Cardiol; 2023 Nov; 27(11):628-638. PubMed ID: 37466024
[TBL] [Abstract][Full Text] [Related]
13. Targeted next-generation sequencing (NGS) of nine candidate genes with custom AmpliSeq in patients and a cardiomyopathy risk group.
Glotov AS; Kazakov SV; Zhukova EA; Alexandrov AV; Glotov OS; Pakin VS; Danilova MM; Poliakova IV; Niyazova SS; Chakova NN; Komissarova SM; Kurnikova EA; Sarana AM; Sherbak SG; Sergushichev AA; Shalyto AA; Baranov VS
Clin Chim Acta; 2015 Jun; 446():132-40. PubMed ID: 25892673
[TBL] [Abstract][Full Text] [Related]
14. Genetic basis of end-stage hypertrophic cardiomyopathy.
Garcia-Pavia P; Vázquez ME; Segovia J; Salas C; Avellana P; Gómez-Bueno M; Vilches C; Gallardo ME; Garesse R; Molano J; Bornstein B; Alonso-Pulpon L
Eur J Heart Fail; 2011 Nov; 13(11):1193-201. PubMed ID: 21896538
[TBL] [Abstract][Full Text] [Related]
15. Whole MYBPC3 NGS sequencing as a molecular strategy to improve the efficiency of molecular diagnosis of patients with hypertrophic cardiomyopathy.
Janin A; Chanavat V; Rollat-Farnier PA; Bardel C; Nguyen K; Chevalier P; Eicher JC; Faivre L; Piard J; Albert E; Nony S; Millat G
Hum Mutat; 2020 Feb; 41(2):465-475. PubMed ID: 31730716
[TBL] [Abstract][Full Text] [Related]
16. Novel phenotype-genotype correlations of hypertrophic cardiomyopathy caused by mutation in α-actin and myosin-binding protein genes in three unrelated Chinese families.
Yang QL; Bian YY; Wang B; Zuo L; Zhou MY; Shao H; Zhang YM; Liu LW
J Cardiol; 2019 May; 73(5):438-444. PubMed ID: 30600190
[TBL] [Abstract][Full Text] [Related]
17. Penetrance of Hypertrophic Cardiomyopathy in Sarcomere Protein Mutation Carriers.
Lorenzini M; Norrish G; Field E; Ochoa JP; Cicerchia M; Akhtar MM; Syrris P; Lopes LR; Kaski JP; Elliott PM
J Am Coll Cardiol; 2020 Aug; 76(5):550-559. PubMed ID: 32731933
[TBL] [Abstract][Full Text] [Related]
18. Defining the diagnostic effectiveness of genes for inclusion in panels: the experience of two decades of genetic testing for hypertrophic cardiomyopathy at a single center.
Mazzarotto F; Girolami F; Boschi B; Barlocco F; Tomberli A; Baldini K; Coppini R; Tanini I; Bardi S; Contini E; Cecchi F; Pelo E; Cook SA; Cerbai E; Poggesi C; Torricelli F; Walsh R; Olivotto I
Genet Med; 2019 Feb; 21(2):284-292. PubMed ID: 29875424
[TBL] [Abstract][Full Text] [Related]
19. Presence of Hypertrophic Cardiomyopathy Related Gene Mutations and Clinical Manifestations in Vietnamese Patients With Hypertrophic Cardiomyopathy.
Tran Vu MT; Nguyen TV; Huynh NV; Nguyen Thai HT; Pham Nguyen V; Ho Huynh TD
Circ J; 2019 Aug; 83(9):1908-1916. PubMed ID: 31308319
[TBL] [Abstract][Full Text] [Related]
20. First identification of homozygous truncating CSRP3 variants in two unrelated cases with hypertrophic cardiomyopathy.
Janin A; Bessière F; Chauveau S; Chevalier P; Millat G
Gene; 2018 Nov; 676():110-116. PubMed ID: 30012424
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
